• SENSEX 80,737.51
    -636.24 (--0.78%)
  • BANKNIFTY 55,599.95
    -303.45 (--0.54%)
  • Yes Bank
    20.77 16.02(%)
  • Vodafone Idea
    6.74 6.46(%)
  • Aptus Value Hou.
    305.00 267.75(%)
  • TCS
    3,399.40 3,060.25(%)
  • Larsen & Toubro
    3,617.00 2,967.65(%)
  • Eternal Ltd
    236.80 146.85(%)
  • Zinka Logistics
    451.35 548.00(%)
  • M & M
    3,065.15 3,276.30(%)
  • HDFC Bank
    1,920.00 1,452.85(%)
  • Garden Reach Sh.
    3,188.75 3,188.75(%)
  • Cochin Shipyard
    2,049.70 2,977.10(%)
  • Reliance Industr
    1,403.00 1,115.55(%)
  • Suzlon Energy
    67.95 45.13(%)
  • Kotak Mah. Bank
    2,033.40 1,602.20(%)
  • Brainbees Solut.
    393.00 734.25(%)
  • Infosys
    1,535.35 1,307.10(%)
  • ICICI Bank
    1,431.75 1,051.50(%)
  • Bharti Airtel
    1,831.75 1,224.50(%)
  • Reliance Power
    58.50 23.26(%)
  • Axis Bank
    1,175.00 934.00(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Ajanta Pharma Ltd Pharmaceuticals - Indian - Formulations

  • Indian Private
  • BSE Code : 13504.0
  • ISIN : INE031B01049
2,559.20 5 (0.20%)
  • As on 03 Jun 2025 (EOD)

  • Today’s Low

    2,513.30

  • Today’s High

    2,585.00

  • Open

    2,547.00

  • Perv Close

    2,554.00

  • 52W Low

    2,111.05

  • 52W High

    3,485.00

Key Indicators

  • P/E(TTM)

    34.86

  • Mar.Cap (₹Cr.)

    31,967.50

  • Div & Yield %

    1.10

  • Book Value(₹)

    290.22

  • Debt-Equity Ratio

    0.20

  • AGM Date

    03-Jun-2025

  • EPS

    73.40

  • P/E Ratio

    34.86

Financials Ratios

  • Debt-Equity Ratio

    0.01

  • Mar.Cap (₹Cr.)

    31,967.50

  • RONW (%)

    23.47

  • ROCE (%)

    31.59

Score Board

  • Equity (₹ in Cr.)

    24.98

  • BV (₹)

    290.20

  • Sales( ₹ in Cr.)

    4,322.04

  • NP (in Cr.)

    916.89

  • NP Var(%)

    15.0

  • Div%

    1400.0

  • CPS (₹)

    84.60

  • EPS (₹)

    73.40

  • Traded Value (₹ in Lakhs)

    31,964.38

  • 52 Week High

    3,485.00

  • 52 Week Low

    2,111.05

  • Price BSE

    2559.0

  • Price NSE

    2,559.00

  • Market Capital( in Cr.)

    31,964.38

  • P/C Ratio

    30.20

  • P/E Ratio

    34.90

  • Price Vs.BV

    73.40

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 3,971.12 3,411.27 3,140.64 2,718.59 2,196.42 1,772.62
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 3,971.12 3,411.27 3,140.64 2,718.59 2,196.42 1,772.62
Other Income 116.48 132.75 139.73 103.57 184.20 102.15
Stock Adjustments 22.17 21.99 56.60 74.60 -9.02 67.38
Total Income 4,109.77 3,566.01 3,336.97 2,896.76 2,371.60 1,942.15
EXPENDITURE :            
Raw Materials 1,101.59 1,027.40 889.16 804.68 654.95 459.50
Power and Fuel Cost 66.44 65.53 54.09 43.42 38.56 33.77
Employee Cost 834.16 720.41 585.87 498.11 437.82 389.37
Other Manufacturing Expenses 168.11 185.50 169.95 119.25 124.80 121.50
Selling and Administration Expenses 587.88 602.95 512.46 324.31 308.60 264.98
Miscellaneous Expenses 115.68 132.19 94.82 86.51 93.81 89.67
Employee Benefit Expenses 834.16 720.41 585.87 498.11 437.82 389.37
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 2,873.86 2,733.98 2,306.35 1,876.28 1,658.54 1,358.79
Operating Profit 1,235.91 832.03 1,030.62 1,020.48 713.06 583.36
Interest 6.80 5.23 9.12 6.90 9.10 0.41
Gross Profit 1,229.11 826.80 1,021.50 1,013.58 703.96 582.95
Depreciation 132.16 126.95 120.96 111.49 91.29 69.90
Profit Before Tax 1,096.95 699.85 900.54 902.09 612.67 513.05
Current Tax 280.56 141.08 171.17 216.68 168.09 108.66
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 9.15 0.05 9.51 9.77 3.45 12.63
Reported Net Profit 807.24 558.72 719.86 675.64 441.13 391.76
Extraordinary Items 11.11 12.87 -0.62 2.91 -2.89 -0.18
Adjusted Net Profit 796.13 545.85 720.48 672.73 444.02 391.94
Adjustment below Net Profit -0.92 -74.72 -68.50 -32.42 -3.85 -0.99
P & L Balance brought forward 3,089.29 2,694.98 2,125.83 1,565.51 1,244.15 932.97
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 642.17 89.69 82.21 82.90 115.93 79.59
P & L Balance carried down 3,253.44 3,089.29 2,694.98 2,125.83 1,565.50 1,244.15
Dividend 642.17 89.69 82.21 82.90 113.44 79.22
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 2,550.00 350.00 475.00 475.00 650.00 450.00
Dividend Per Share(Rs) 51.00 7.00 9.50 9.50 13.00 9.00
Earnings Per Share-Unit Curr 63.89 44.22 83.85 77.70 50.30 44.67
Earnings Per Share(Adj)-Unit Curr 63.89 44.22 55.90 51.80 33.53 29.78
Book Value 270.17 256.94 369.15 331.80 280.65 244.25
Book Value(Adj)-Unit Curr 270.17 256.94 246.10 221.20 187.10 162.83

Shareholding Pattern

  • Promoter Group

    66.26%

  • Public Share Holding

    33.74%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 12,588,393 10.08 12,588,393 1
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 70,175,384 56.18 70,175,384 7
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 82,763,777 66.26 82,763,777 8
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 10,955 0.01 10,955 1
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 55 0.00 55 1
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 11,070,927 8.86 11,070,927 313
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 1,977,321 1.58 1,977,321 14
Mutual Funds / UTI 18,896,922 15.13 18,896,922 28
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 963,218 0.77 963,218 28
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 32,919,398 26.35 32,919,398 385
2] Non Institution
Bodies Corporate 217,826 0.17 216,701 562
Clearing Members 1,082 0.00 1,082 6
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 386,853 0.31 386,853 2,665
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 173,679 0.14 173,679 1,213
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 852,988 0.68 852,988 5
Individuals holding nominal share capital up to Rs. 1 lakh 7,432,605 5.95 7,265,656 65,916
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 520 0.00 520 3
Others 135,121 0.11 135,121 3
Sub Total 9,228,924 7.39 9,060,850 70,434
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 124,912,099 100.00 124,744,025 70,827

Company Background

Ajanta Pharma LtdPharmaceuticals - Indian - Formulations

  • Ajanta Pharma Ltd
  • BSE Code : 13504.0
  • ISIN : INE031B01049

  • Incorporation Year

    1979

  • Registered Office

    Ajanta House
    Charkop Kandivli (W), Mumbai,
    Maharashtra-400067

  • Telephone

    91-22-66061000/1204/1203

  • FAX

    91-22-66061200/1300

  • Chairman

    Mannalal B Agrawal

  • Managing Director

    Yogesh Agrawal

  • Company Secretary

    Gaurang Shah

  • Auditor

    B S R & Co LLP

  • Face Value

    2

  • Listing

    NSE

  • Registrar

    MUFG Intime India Pvt Ltd
    C-101 247 Park,
    L B S Marg,Vikhroli West
    Mumbai - Mumbai-400083

Ajanta Pharma Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Ajanta Pharma 2,558.95 4,087.60 3,971.12 34.86 32.49
Abbott India 31,061.15 6,097.18 5,848.91 46.66 44.71
Astrazeneca Phar 9,334.25 1,330.33 1,295.53 201.60 33.26
P & G Health Ltd 5,742.35 1,166.89 1,151.26 37.95 39.76
Glaxosmi. Pharma 3,223.65 3,530.73 3,407.25 59.42 44.44
Cipla 1,472.80 17,645.00 16,574.34 23.06 20.10
Amrutanjan Healt 730.95 437.58 421.23 41.58 20.84
Fermenta Biotec. 324.00 315.24 307.09 14.11 4.10
Guj. Themis Bio. 306.40 174.19 169.82 68.39 44.82
Bliss GVS Pharma 133.00 638.96 605.46 20.31 11.19
Ambalal Sarabhai 37.52 11.70 3.81 34.74 1.92